Avoid common mistakes on your manuscript.
To the Editor: Metformin is the most widely prescribed medication for the prevention and treatment of type 2 diabetes. Exercise and weight loss are the most effective lifestyle interventions for type 2 diabetes therapy. Recently, a number of diverse studies have discovered that metformin impairs exercise conditioning and limits exercise-induced mitochondrial genesis and function (Konopka et al. 2019; Walton et al. 2019). Additionally, metformin attenuates exercise-induced insulin sensitivity (Sharoff et al. 2010). Explanations for the non-beneficial effects of metformin on exercise are being explored but have not yielded clear answers. We propose that metformin’s well-documented activation of AMPK (AMP-activated protein kinase) leads to phosphorylation of HSF1 (heat shock factor 1) at serine 121, thereby partially inactivating HSF1 and diminishing the cellular stress response (Dai et al. 2015). Exercise normally activates HSF1 and the cellular stress response. Indeed, Hsp72 transgenic mice endure exhaustive exercise four times longer than their wild counterpart. The Hsp72 transgenic skeletal muscle has robust mitochondria—both in number and in activity (Henstridge et al. 2014). Furthermore, HSF1 improves insulin sensitivity and glycemic control (Hooper et al. 2014). Combining two effective therapies can lead to unintended loss of therapeutic efficacy. Understanding the complex interactions of cellular stress pathways can be essential in arriving at viable answers.
The author has no financial or nonfinancial interests that are directly or indirectly related to the work submitted for publication. The work on this project was not funded.
References
Dai S, Tang Z, Cao J et al (2015) Suppression of the HSF 1-mediated proteotoxic stress response by the metabolic stress sensor AMPK. EMBO J 34:275–293
Henstridge DC, Bruce CR, Drew BG et al (2014) Activating HSP72 in rodent skeletal muscle increases mitochondrial number and oxidative capacity and decreases insulin resistance. Diabetes 63:1881–1894
Hooper PL, Balogh G, Rivas E et al (2014) The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes. Cell Stress Chaperones 19:447–464
Konopka AR, Laurin JL, Schoenberg HM et al (2019) Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell 18:e12880
Sharoff CG, Hagobian TA, Malin SK et al (2010) Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin-resistant individuals. Am J Physiol-Endocrinol Metab 298:E815–E823
Walton RG, Dungan CM, Long DE et al (2019) Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: a randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial. Aging Cell 18:e13039. https://doi.org/10.1111/acel.13039
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hooper, P.L. Attenuation of exercise conditioning by metformin—a consequence of HSF1 inhibition. Cell Stress and Chaperones 27, 307 (2022). https://doi.org/10.1007/s12192-022-01276-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12192-022-01276-y